BARBARA KLEIN: But what about reducing pain? Aspirin competes with other medicines for reducing pain and high body temperature. The competition includes acetaminophen, the active substance in products like Tylenol. Like the medicine ibuprofen, aspirin is an NSAID -- a non-steroidal anti-inflammatory drug.
Several studies have found that men who take aspirin and other NSAIDS have a decreased risk of prostate cancer. The prostate is part of the male reproductive system.
MARIO RITTER: Researchers at the Mayo Clinic in Minnesota wanted to see how NSAIDs might affect prostates that are enlarged but not cancerous. They followed the health of two thousand, five hundred men for twelve years.
The researchers said these drugs may delay or stop development of an enlarged prostate. They said the risk of an enlarged prostate was fifty percent lower in the NSAID users than the other men. The risk of bladder problems was thirty-five percent lower.
(MUSIC)
BARBARA KLEIN: Other studies have suggested that aspirin can help with cancer prevention and survival. They showed that aspirin may help prevent cancers of the stomach, intestines and colon.
Researchers reported two years ago about people who had colorectal cancer. They found that aspirin users had an almost thirty percent lower risk of dying from their cancer. That was during an average of eleven years after the cancer was discovered.
Earlier this month, The Lancet medical journal published findings from a study of aspirin and cancer. Researchers followed almost one thousand patients who had Lynch syndrome – a genetic condition that makes them likely to develop some cancers. One group of patients took six hundred milligrams of aspirin a day for at least two years. These patients had a sixty-three percent lower risk of colorectal cancer than those who took a harmless substance or placebo. The longer they took aspirin, the lower their risk of cancer.
最新
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25
2013-11-25